Surprisingly, although anti-IL-17 therapies showed astonishing clinical efficacy in improving psoriasis, in vitro studies of cultured monolayer keratinocytes identified a restricted number of genes induced by IL-17 [10], [12]. Here, IL17A is linked to psoriasis.